Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GEOC

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 8
Rounds per year 0.82
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Medical Device
  • Health Care
  • Manufacturing
  • Biotechnology
  • Therapeutics
Summary

GEOC appeared to be the VC, which was created in 2013. The company was established in Asia in China. The main office of represented VC is situated in the Shanghai.

Among the various public portfolio startups of the fund, we may underline Sight Diagnostics, Cnoga Medical, Vectorious Medical Technologies Among the most popular fund investment industries, there are Printing, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from GEOC is 100-500 millions dollars. The high activity for fund was in 2014.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the GEOC, startups are often financed by OurCrowd, GE Healthcare, Elbit Imaging Ltd.. The meaningful sponsors for the fund in investment in the same round are York Capital Management, GE Healthcare, Elbit Imaging Ltd.. In the next rounds fund is usually obtained by OurCrowd, Go Capital, York Capital Management.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GEOC:
Typical Co-investors
GEOC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GEOC:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Block.one Cayman Islands, Midland
China Investment Fund China, Hong Kong, Hong Kong Island
China Summit Capital China, Shanghai
Finn Evdemon Capital Partners Central, Central Region, Singapore
GMGMT Bayern, Germany, Munich
Hearst Television Inc. New York, New York, United States
Invia.cz Czechia, Prague, Prague
JSS Management -
Killik & Co England, London, United Kingdom
Mantella Venture Partners Canada, Ontario, Toronto
NIF SMBC Ventures California, Palo Alto, United States
Nissei Capital Chiyoda, Japan
Quaras Japan, Tokyo
Robeco Private Equity -
Shengyi Kechuang Beijing, Beijing, China
The Abhoca Group -
U.S. Department of the Treasury District of Columbia, United States, Washington
ValueTech Seed Mazowieckie, Poland, Warsaw
Weipinhui China, Guangdong, Guangzhou
Xiangxiang Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Vectorious Medical Technologies

Health Care
Information Technology
Medical
Medical Device
Wireless
$9M09 May 2018 Tel Aviv District

Sight Diagnostics

Artificial Intelligence
Computer Vision
Health Care
Health Diagnostics
Machine Learning
Medical
Medical Device
$16M01 Sep 2016 Tel Aviv-Yafo, Tel Aviv District, Israel

Kaymera

Cyber Security
Mobile
National Security
Security
$13M01 Jan 2015 Israel, Tel Aviv District

Food and Beverage
Food Processing
Manufacturing
$463K31 May 2012 Shanxi

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GEOC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 32M
Rounds per year 0.82
Peak activity year 2015
Lead investments 2
Follow on index 0.11
Exits 2
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Vectorious Medical Technologies

Health Care
Information Technology
Medical
Medical Device
Wireless
$9M09 May 2018 Tel Aviv District

Sight Diagnostics

Artificial Intelligence
Computer Vision
Health Care
Health Diagnostics
Machine Learning
Medical
Medical Device
$16M01 Sep 2016 Tel Aviv-Yafo, Tel Aviv District, Israel

Kaymera

Cyber Security
Mobile
National Security
Security
$13M01 Jan 2015 Israel, Tel Aviv District

Food and Beverage
Food Processing
Manufacturing
$463K31 May 2012 Shanxi
Crunchbase icon

Content report

The following text will be sent to our editors: